Back to news index
Hands-only CPR, pushy dispatchers are lifesavers
(AP)
AP - More bystanders are willing to attempt CPR if an emergency dispatcher gives them firm and direct instructions — especially if they can just press on the chest and skip the mouth-to-mouth, according to new research.
DC pushes female condoms to fight HIV epidemic
(AP)
AP - Charlene Cotton will talk to anyone about sex. Several days a week she stands behind a table decorated with a bowl of flavored condoms and safer sex pamphlets, calling to women passing on the street, "Come check out my table. Don't be scared."
NYC looks to stop spreading bedbug infestations
(AP)
AP - One of every 15 New Yorkers battled bedbugs last year, officials said Wednesday as they announced a plan to fight the spreading infestation, including a public-awareness campaign and a top entomologist to head the effort.
New program rebuilding faces of soldiers, veterans
(AP)
AP - Master Sgt. Todd Nelson lost his right eye and ear in a flash when a car bomb in Afghanistan exploded, sending fire up his arm and over his head.
Tests aim to settle if fresher blood works better
(AP)
AP - Facing surgery? You could receive blood that's been stored for a week, or three weeks, or nearly six — and there's growing concern that people who get the older blood might not fare as well.
Japanese women extend life expectancy to new high
(AP)
AP - Japanese women are expected to live almost 86 1/2 years, topping the world longevity ratings for the 25th straight year, the government reported Monday.
Knee, Hip Replacements May Aid Weight Loss: Study
(HealthDay)
HealthDay - THURSDAY, July 29 (HealthDay News) -- Weight loss has been noted
among patients who've had a knee or hip replacement, a new study says.
New Study Finds HPV Vaccine Protects Against Genital Warts
(HealthDay)
HealthDay - TUESDAY, July 20 (HealthDay News) -- A new study finds that the
human papillomavirus (HPV) vaccine protects not only against the sexually
transmitted virus that causes cervical cancer, but also helps prevent
genital warts and low-grade cervical growths.
Clinical Trials Update: July 29, 2010
(HealthDay)
HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
Health Tip: Dealing With Separation Anxiety
(HealthDay)
HealthDay - (HealthDay News) -- It's common for young children to have a
tough time when mom or dad leaves them with someone else.
Calcium supplements linked to heart attacks: study
(AFP)
AFP - Ordinary calcium supplements taken by the elderly to strengthen bones may boost the risk of heart attacks, according to a study released Friday.
Prostate Cancer 'Cell of Origin' Identified
(LiveScience.com)
LiveScience.com - For researchers, a
key to studying any cancer is finding its "cell of origin." Now
scientists at the University of California at Los Angeles say they've found
just that -- a specific type of cell that gives rise to prostate cancer.
Court ruling could pave way for Gemzar generics
(Reuters)
Reuters - A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co's Gemzar cancer drug to be launched in the United States beginning in mid-November.
Kids Adopted By Same-Sex Couples 'Thriving': Researcher
(HealthDay)
HealthDay - THURSDAY, July 29 (HealthDay News) -- Children adopted by gay or
lesbian parents develop as well as those adopted by heterosexual couples,
a new study has found.
New fronts in AIDS war, but funding foe is back
(AFP)
AFP - The 18th council of war on AIDS has opened up new fronts in a nearly three-decade-old campaign but in the grim awareness that a battle-hardened enemy -- the money crunch -- is back.
Health Tip: Is Your Blood Sugar High?
(HealthDay)
HealthDay - (HealthDay News) -- Hyperglycemia, the medical term for high
blood sugar, is a prime cause of complications among people with
diabetes.
Experts identify three culprits for gluten allergy
(Reuters)
Reuters - Researchers have identified three fragments in gluten that appear to trigger a disorder in people who are allergic to the wheat protein.
Obese patients lose weight on new Orexigen drug
(Reuters)
Reuters - Overweight volunteers who took Orexigen's experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday.
